DUBLIN--(BUSINESS WIRE)--The "Global Nicotine Gum Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The nicotine gum market will register a CAGR of over 5% by 2023.
Increase in number of people quitting smoking to drive market growth
It is estimated that tobacco will cause more than 8 million deaths annually by 2030. In the US, cigarette smoking is responsible for nearly 480,000 deaths every year.
The number of quit attempts it takes before smokers are successful at quitting smoking varies. According to the American Cancer Society, it takes about 8-10 quit attempts, while the Australian Cancer Council suggests that it takes 12-14 attempts to quit the habit of smoking.
Growing enrolment in smoking cessation therapies
The smoking cessation therapy is gaining popularity among consumers who are trying to quit smoking, and in certain countries, governments are sponsoring smoking cessation therapy programs.
In the US, Department of Health and Human Services is sponsoring tobacco cessation programs through its supported health centers. Thus, the increasing application of nicotine gums as a medium to help consumers quit smoking will help in the growth of the global nicotine gums market during the forecast period.
Presence of substitute products
The availability of many substitute products can negatively influence the growth of the market during the forecast period. Nicotine patches, nicotine snus, nasal sprays, inhalers, and lozenges are some of the substitutes to nicotine gum. The emergence of e-cigarettes has considerably challenged the growth of the market.
Competitive Landscape
The market appears to be fragmented, and with the presence of several companies including GlaxoSmithKline and ITC Limited, the competitive environment is quite intense.
Key Players
- British American Tobacco
- GlaxoSmithKline
- ITC Limited
- Johnson & Johnson Services
- Novartis
Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Comparison by product
- 2-mg nicotine - Market size and forecast 2018-2023
- 4-mg nicotine - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- South America - Market size and forecast 2018-2023
- MEA - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
- New product launches
- Increase in number of people quitting smoking
- Addiction to nicotine gums
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- British American Tobacco
- GlaxoSmithKline
- ITC Limited
- Johnson & Johnson Services
- Novartis
For more information about this report visit https://www.researchandmarkets.com/research/6l4nj4/global_nicotine?w=4
